This ad started running late in 2018, and the article below was first published on February 4, 2019… the ad is sending a lot of questions our way this week and is almost entirely unchanged, and the article below is lightly updated to share some more recent news and developments. The promise in Dave Forest’s […]
Articles
Christian DeHaemer was an eager evangelist for “blood in the streets” investing many years ago, when we first started covering his hyped-up hints about earthshaking discoveries and — but it’s not the the Rothschild “buy when there’s blood in the streets” dictum, it’s quite a bit more literal. He has long talked of buying stocks […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...
Thanks, I didn’t run across the Boston presentation....
SGMO has lost nearly half it's value since late Aug., 2018! What has the market done since then??? NEXT!!!...
If SGMO had anything worth pursuing they would have been bought out by now. Wait until they get approval and start makin...
SGMO is down 34% at 1:30 EST. Down more at 11:30, but seem to have risen a little....
It is Sangamo Therapeutics ( SGMO )....
The ONLY gene editing stock to own is SGMO. No off targets unlike the rest. 7 readouts this year. Imo, will cure HIV ...
Does anyone own Sangamo Therapeutics. (SGMO) I should call myself the "Greenhorn" because I know virtually nothing about...
Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...
SGMO down 20% today looks like things didn't go so well: https://www.marketwatch.com/story/sangamo-stock-drops-13-pre...
Good results but shares drop 20% good spot from Travis, on the opportunity to buy as it happens that would seem to be t...
Right, that's the dream of future possibility... but the first trial data is for a very small disease. Not unusual, jus...
Hi All , Sangamo are holding a conference call today just after the presentation in Greece, The call will follow the ...
https://www.fool.com/investing/2018/09/03/why-sangamo-therapeutics-shot-337-higher-in-august.aspx...
As usual - you got it right...:) Confirming its SGMO, recommended up to 20.00 or the SGMO Sept 2018 17 calls for 3 or ...
I own a few shares of SGMO, along with CRSP, EDIT, and NLT, and 16 other micro cap Biogen stocks, and I feel that this i...
NOVUS reported the following top five 2015 Q1 hedge fund stock-pickers in the Healthcare sector: RA Cap Management; BB...
Patents by Assignee Sangamo Biosciences, Inc. http://patents.justia.com/assignee/sangamo-biosciences-inc...
Long post alert. Mostly for Doc KSS. I remember Sangamo Biosciences ($SGMO) being discussed earlier w.r.t. BLUE. I was ...
Leo S - RE: Biotechnology Threads Focus- My point is Leo S Look at the BioTech equities that increased Thursday and Frid...
The following info about RA Capital's holdings, as at end of 2013 may be of interest to some of you: 37 Positions as of...
Hi Booya (maybe you are Cramer) re your reply on March 5th to the original post #10 dated 1/8/2014 on Sangamo Bioscience...
SGMO Trading at $23.75ish off a $19.61 close on the news below. Sangamo BioSciences announced the publication in t...
I own shares of Sangamo Biosciences (SGMO). Sangamo is focused on the research and commercial development of engineered ...